Skip to main content

ALSUntangled No. 37: Inosine.

Publication ,  Journal Article
ALSUntangled Group,
Published in: Amyotroph Lateral Scler Frontotemporal Degener
May 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Amyotroph Lateral Scler Frontotemporal Degener

DOI

EISSN

2167-9223

Publication Date

May 2017

Volume

18

Issue

3-4

Start / End Page

309 / 312

Location

England

Related Subject Headings

  • Treatment Outcome
  • Risk
  • Inosine
  • Humans
  • Clinical Trials as Topic
  • Amyotrophic Lateral Sclerosis
  • 3209 Neurosciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
ALSUntangled Group, . (2017). ALSUntangled No. 37: Inosine. Amyotroph Lateral Scler Frontotemporal Degener, 18(3–4), 309–312. https://doi.org/10.1080/21678421.2016.1223270
ALSUntangled Group, Hiroshi. “ALSUntangled No. 37: Inosine.Amyotroph Lateral Scler Frontotemporal Degener 18, no. 3–4 (May 2017): 309–12. https://doi.org/10.1080/21678421.2016.1223270.
ALSUntangled Group. ALSUntangled No. 37: Inosine. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3–4):309–12.
ALSUntangled Group, Hiroshi. “ALSUntangled No. 37: Inosine.Amyotroph Lateral Scler Frontotemporal Degener, vol. 18, no. 3–4, May 2017, pp. 309–12. Pubmed, doi:10.1080/21678421.2016.1223270.
ALSUntangled Group. ALSUntangled No. 37: Inosine. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3–4):309–312.

Published In

Amyotroph Lateral Scler Frontotemporal Degener

DOI

EISSN

2167-9223

Publication Date

May 2017

Volume

18

Issue

3-4

Start / End Page

309 / 312

Location

England

Related Subject Headings

  • Treatment Outcome
  • Risk
  • Inosine
  • Humans
  • Clinical Trials as Topic
  • Amyotrophic Lateral Sclerosis
  • 3209 Neurosciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences